Christopher Beck
Geschäftsführer bei CONTEXT THERAPEUTICS INC.
Profil
Christopher Beck is a professional with experience in various pharmaceutical companies.
He is currently working as Senior Vice President-Operations at Context Therapeutics, Inc. Prior to this, he worked as Vice President-Program Management at Galera Therapeutics, Aevi Genomic Medicine, and Formular Pharmaceuticals.
He completed his undergraduate degree at Drexel University and earned an MBA from The Pennsylvania State University.
Aktive Positionen von Christopher Beck
| Unternehmen | Position | Beginn |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Geschäftsführer | 05.01.2022 |
Ehemalige bekannte Positionen von Christopher Beck
| Unternehmen | Position | Ende |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Corporate Officer/Principal | - |
| Formular Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Christopher Beck
| Drexel University | Undergraduate Degree |
| The Pennsylvania State University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| CONTEXT THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
| Formular Pharmaceuticals, Inc. |